Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy

Blood Transfus. 2020 Jul;18(4):328. doi: 10.2450/2020.0164-20.

Authors

Daniela Dragonetti¹, Giuseppe Guarini², Michele Pizzuti³

Affiliations

¹ Department of Clinical Laboratory, "San Carlo" Regional Hospital, Potenza, Italy.
² COVID Intensive Care, "San Carlo" Regional Hospital, Potenza, Italy.
³ Department of Hematology, "San Carlo" Regional Hospital, Potenza, Italy.

No abstract available

Publication types

Comparative Study
Letter

MeSH terms

Antibody Specificity
Anticoagulants / immunology*
Anticoagulants / therapeutic use
Autoantibodies / blood*
Autoantibodies / immunology
Betacoronavirus*
COVID-19
Coronavirus Infections / blood
Coronavirus Infections / complications
Coronavirus Infections / immunology*
Fondaparinux / pharmacology
Fondaparinux / therapeutic use
Heparin / immunology*
Heparin / therapeutic use
Heparin, Low-Molecular-Weight / immunology*
Heparin, Low-Molecular-Weight / therapeutic use
Humans
Pandemics
Platelet Count
Platelet Factor 4 / immunology*
Pneumonia, Viral / blood
Pneumonia, Viral / complications
Pneumonia, Viral / immunology*
Purpura, Thrombocytopenic, Idiopathic / chemically induced*
Purpura, Thrombocytopenic, Idiopathic / immunology
SARS-CoV-2
Thrombophilia / drug therapy*
Thrombophilia / immunology

Substances

Anticoagulants
Autoantibodies
Heparin, Low-Molecular-Weight
Platelet Factor 4
Heparin
Fondaparinux